Pharmaceutical antibody compositions with resistance to soluble CEA

Details for Australian Patent Application No. 2006328882 (hide)

Owner Micromet AG

Inventors Raum, Tobias; Kufer, Peter; Rau, Doris; Mangold, Susanne

Agent Griffith Hack

Pub. Number AU-B-2006328882

PCT Pub. Number WO2007/071422

Priority 05028063.5 21.12.05 EP; 60/752,029 21.12.05 US

Filing date 21 December 2006

Wipo publication date 28 June 2007

Acceptance publication date 16 June 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/071422 Priority application(s): WO2007/071422

16 June 2011 Application Accepted

  Published as AU-B-2006328882

13 October 2011 Standard Patent Sealed

20 September 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Griffith Hack GPO Box 1285 Melbourne VIC 3001

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006328886-Pharmaceutical compositions with resistance to soluble CEA

2006328880-Bursting pellets